A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
Clinical trial NCT05911763 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05911763
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-30
- Primary completion
- 2028-06-06
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.